UB Paderborn / Katalog / Suche / in CDI

Long‐Term Testosterone Treatment in Elderly Men with Hypogonadism and Erectile Dysfunction Reduces Obesity Parameters and Improves Metabolic Syndrome and Health‐Related Quality of Life

Journal of sexual medicine, 2014-06, Vol.11 (6), p.1567-1576

2014

Volltextzugriff (PDF)

International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy

Journal of clinical oncology, 2002-08, Vol.20 (15), p.3206-3212

2002

Volltextzugriff (PDF)

Insignificant Prostate Cancer in Radical Prostatectomy Specimen: Time Trends and Preoperative Prediction

European urology, 2003-05, Vol.43 (5), p.455-460

2003

Volltextzugriff (PDF)

Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study

World journal of urology, 2014-08, Vol.32 (4), p.1049-1054

2014

Volltextzugriff (PDF)

Health-Related Quality of Life in 536 Long-Term Prostate Cancer Survivors after Treatment with Leuprorelin Acetate: A Combined Retrospective and Prospective Analysis

Urologia internationalis, 2018-01, Vol.100 (1), p.72-78

2018

Volltextzugriff (PDF)

A Preoperative Nomogram Identifying Decreased Risk of Positive Pelvic Lymph Nodes in Patients With Prostate Cancer

The Journal of urology, 2003-11, Vol.170 (5), p.1798-1803

2003

Volltextzugriff (PDF)

Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?

Urology (Ridgewood, N.J.), 2003-07, Vol.62 (1), p.79-85

2003

Volltextzugriff (PDF)

Combined Testosterone and Vardenafil Treatment for Restoring Erectile Function in Hypogonadal Patients who Failed to Respond to Testosterone Therapy Alone

Journal of sexual medicine, 2014-02, Vol.11 (2), p.543-552

2014

Volltextzugriff (PDF)

372 TESTOSTERONE TREATMENT IN ELDERLY HYPOGONADAL PATIENTS DOES NOT INCREASE PROSTATE CANCER RISK RESULTS OF A PROSPECTIVE COMPARATIVE STUDY. 7 YEARS FOLLOW UP ANALYSIS TO AGE-MATCHED CONTROLS

The Journal of urology, 2012-04, Vol.187 (4), p.e152-e152

2012

Volltextzugriff (PDF)

Prognostic Significance of Visible Lesions on Transrectal Ultrasound in Impalpable Prostate Cancers: Implications for Staging

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2860-2868

2003

Volltextzugriff (PDF)

Prostate Biopsy Core Handling: Comparison of Contemporary Preembedding Methods

Urologia internationalis, 2015-01, Vol.95 (2), p.203-208

2015

Volltextzugriff (PDF)

A VALIDATED STRATEGY FOR SIDE SPECIFIC PREDICTION OF ORGAN CONFINED PROSTATE CANCER: A TOOL TO SELECT FOR NERVE SPARING RADICAL PROSTATECTOMY

The Journal of urology, 2001-03, Vol.165 (3), p.857-863

2001

Volltextzugriff (PDF)

Analysis of Clinical Stage T2 Prostate Cancer: Do Current Subclassifications Represent an Improvement?

Journal of clinical oncology, 2002-04, Vol.20 (8), p.2025-2030

2002

Volltextzugriff (PDF)

Prostate cancers in the transition zone: Part 2; clinical aspects

BJU international, 2004-12, Vol.94 (9), p.1226-1229

2004

Volltextzugriff (PDF)

PROSPECTIVE VALIDATION OF AN ALGORITHM WITH SYSTEMATIC SEXTANT BIOPSY TO PREDICT PELVIC LYMPH NODE METASTASIS IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATIC CARCINOMA

The Journal of urology, 2002-02, Vol.167 (2), p.521-525

2002

Volltextzugriff (PDF)

Can Predictive Models for Prostate Cancer Patients Derived in the United States of America Be Utilized in European Patients? A Validation Study of the Partin Tables

European urology, 2003, Vol.43 (1), p.6-11

2003

Volltextzugriff (PDF)

Using prostate‐specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer

BJU international, 2006-07, Vol.98 (1), p.11-19

2006

Volltextzugriff (PDF)

Assessment of the Enhancement in Predictive Accuracy Provided by Systematic Biopsy in Predicting Outcome for Clinically Localized Prostate Cancer

The Journal of urology, 2004, Vol.171 (1), p.200-203

2004

Volltextzugriff (PDF)

A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men

Urologic oncology, 2002-07, Vol.7 (4), p.141-146

2002

Volltextzugriff (PDF)

Assessment of Clinical and Pathologic Characteristics Predisposing to Disease Recurrence Following Radical Prostatectomy in Men with Pathologically Organ-Confined Prostate Cancer

European urology, 2002-02, Vol.41 (2), p.155-161

2002

Volltextzugriff (PDF)

PERCENT FREE PROSTATE SPECIFIC ANTIGEN IS NOT AN INDEPENDENT PREDICTOR OF ORGAN CONFINEMENT OR PROSTATE SPECIFIC ANTIGEN RECURRENCE IN UNSCREENED PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY

The Journal of urology, 2002-03, Vol.167 (3), p.1306-1309

2002

Volltextzugriff (PDF)

Is Year of Radical Prostatectomy a Predictor of Outcome in Prostate Cancer?

The Journal of urology, 2004-02, Vol.171 (2), p.692-696

2004

Volltextzugriff (PDF)

Alkaline phosphatase (ALP) decline and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the REASSURE study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5041-5041

2022

Volltextzugriff (PDF)

Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy

Journal of cancer research and clinical oncology, 2003-11, Vol.129 (11), p.662-668

2003

Volltextzugriff (PDF)

Comparison of ultrasound imaging in patients undergoing transperineal and transrectal prostate ultrasound

Urology (Ridgewood, N.J.), 1998-12, Vol.52 (6), p.1070-1072

1998

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Long‐Term Testosterone Treatment in Elderly Men with Hypogonadism and Erectile Dysfunction Reduces Obesity Parameters and Improves Metabolic Syndrome and Health‐Related Quality of Life

International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy

Insignificant Prostate Cancer in Radical Prostatectomy Specimen: Time Trends and Preoperative Prediction

Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study

Health-Related Quality of Life in 536 Long-Term Prostate Cancer Survivors after Treatment with Leuprorelin Acetate: A Combined Retrospective and Prospective Analysis

A Preoperative Nomogram Identifying Decreased Risk of Positive Pelvic Lymph Nodes in Patients With Prostate Cancer

Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?

Combined Testosterone and Vardenafil Treatment for Restoring Erectile Function in Hypogonadal Patients who Failed to Respond to Testosterone Therapy Alone

372 TESTOSTERONE TREATMENT IN ELDERLY HYPOGONADAL PATIENTS DOES NOT INCREASE PROSTATE CANCER RISK RESULTS OF A PROSPECTIVE COMPARATIVE STUDY. 7 YEARS FOLLOW UP ANALYSIS TO AGE-MATCHED CONTROLS

Prognostic Significance of Visible Lesions on Transrectal Ultrasound in Impalpable Prostate Cancers: Implications for Staging

Prostate Biopsy Core Handling: Comparison of Contemporary Preembedding Methods

A VALIDATED STRATEGY FOR SIDE SPECIFIC PREDICTION OF ORGAN CONFINED PROSTATE CANCER: A TOOL TO SELECT FOR NERVE SPARING RADICAL PROSTATECTOMY

Analysis of Clinical Stage T2 Prostate Cancer: Do Current Subclassifications Represent an Improvement?

Prostate cancers in the transition zone: Part 2; clinical aspects

PROSPECTIVE VALIDATION OF AN ALGORITHM WITH SYSTEMATIC SEXTANT BIOPSY TO PREDICT PELVIC LYMPH NODE METASTASIS IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATIC CARCINOMA

Can Predictive Models for Prostate Cancer Patients Derived in the United States of America Be Utilized in European Patients? A Validation Study of the Partin Tables

Using prostate‐specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer

Assessment of the Enhancement in Predictive Accuracy Provided by Systematic Biopsy in Predicting Outcome for Clinically Localized Prostate Cancer

A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men

Assessment of Clinical and Pathologic Characteristics Predisposing to Disease Recurrence Following Radical Prostatectomy in Men with Pathologically Organ-Confined Prostate Cancer

PERCENT FREE PROSTATE SPECIFIC ANTIGEN IS NOT AN INDEPENDENT PREDICTOR OF ORGAN CONFINEMENT OR PROSTATE SPECIFIC ANTIGEN RECURRENCE IN UNSCREENED PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY

Is Year of Radical Prostatectomy a Predictor of Outcome in Prostate Cancer?

Alkaline phosphatase (ALP) decline and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the REASSURE study

Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy

Comparison of ultrasound imaging in patients undergoing transperineal and transrectal prostate ultrasound

Suchergebnisse filtern